StockpollyBeta
Get App
Popularity #4,566
SCLX · NASDAQ · Drug Manufacturers - General

Scilex (SCLX)

Commercializes non-opioid treatments for acute and chronic pain.

$5.36
After-hours close−0.00 (−0.06%)
At close$5.36(+3.88%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue10131116141551011598
Cost of revenue364445133447
Gross profit787121110477141
4626272831393227194383631
Research & development433222264833
Selling, general & administrative4024292530352820189303127
Other expenses10−61−11111020
Operating income−39−18−19−16−20−28−28−21−187−37−32−29
3−3−5−2216222−24−71−9−13−86
Interest expense111110233346
Other non-operating income−43421−16−22−421695100
Income before tax−36−21−24−38−4−6−26−44−258−46−46−115
Income tax expense000000000000
Net income from continuing operations−36−21−24−38−4−6−26−44−258−46−46−115
Other adjustments0000000−440000
Net income−36−21−24−38−4−6−26−86−257−33−43−114
EPS, basic−$8.89−$7.49−$6.69−$10.94−$1.21−$1.23−$3.77−$12.43−$37.17−$4.78−$6.28−$16.65
EPS, diluted−$8.89−$7.49−$6.69−$10.94−$1.21−$1.23−$3.77−$12.43−$37.17−$4.78−$6.28−$16.65
Weighted average shares, basic444347777777
Weighted average shares, diluted444347777777
EBITDA−34−20−23−36−3−5−23−40−254−41−39−27
Depreciation & amortization111111111233
EBIT−35−21−24−37−4−6−24−41−255−43−42−29